drug

tofersen sodium

Marketedupdated 2mo ago

by $BIIB BIOGEN INC.

Approved

community read0 votes

indications

investigational

ALS

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 31m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Apr 25, 2028

~1.8 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Apr 1, 2035compositionUS 10385341
Apr 1, 2035method-of-use (U-3575)US 10669546
Apr 1, 2035method-of-use (U-3575)US 10968453

FDA exclusivities (2)

Apr 25, 2030ODE-432Orphan Drug (7y)3.8y
Apr 25, 2028NCENew Chemical Entity (5y)1.8y